Production —
Training activity: 7

Details

Distribute a product

Complete the required documentation and evaluate the recall process

Suggest improvements where appropriate

Type

Entrustable training activity (ETA)

Evidence requirements

Evidence the activity has been undertaken by the trainee repeatedly, consistently, and effectively over time, in a range of situations. This may include occasions where the trainee has not successfully achieved the outcome of the activity themselves. For example, because it was not appropriate to undertake the task in the circumstances or the trainees recognised their own limitations and sought help or advice to ensure the activity reached an appropriate conclusion. ​

Reflection at multiple timepoints on the trainee learning journey for this activity.

Reflective practice guidance

The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.

Before action

What does success look like?

• How will reviewing the specified learning outcomes help you focus on the requirement to support the safe storage and distribution of medicinal products using the principles of Good Distribution Practice (GDP)?
• In what ways will this activity demonstrate your ability to describe the working practices of pharmaceutical production and apply Quality Risk Management (QRM) to the distribution and recall process?
• What evidence—such as accurately completed distribution logs or a rigorous critique of a recall simulation—will indicate that you have successfully met the expectations for Good Manufacturing Practice (GMP) and pharmaceutical quality management systems (PQS)?
• How will you use a discussion with your Training Officer to gain clarity on the specific documentation standards and the department’s current recall plan?

What is your prior experience of this activity?

• What do you already know about the practical steps involved in product distribution and the associated legal or quality documentation requirements?
• What previous experience do you have in observing or participating in product recalls or quality meetings where the implications for patient safety and product availability were discussed?
• What challenges do you anticipate, such as identifying subtle weaknesses in a complex recall system or ensuring the integrity of the supply chain during distribution?
• How will you define the scope of your own practice, and at what point—such as during a critical non-conformance or a high-risk recall scenario—would you need to seek advice from a senior colleague?
• How do you feel about embarking on this activity, particularly the responsibility of evaluating a process as critical as a product recall?

What do you anticipate you will learn from the experience?

• What specific knowledge do you hope to gain regarding the interdependence between distribution documentation and the ability to conduct an effective recall?
• How do you expect this activity to enhance your understanding of how GDP directly impacts product quality and patient safety?
• What insights do you hope to gain into the complexities of a recall process and the analytical techniques used to suggest meaningful improvements?
• How will this experience improve your ability to critically analyse production and distribution data to identify systemic trends or areas of concern?

What additional considerations do you need to make?

• How will you consult actions identified following previous experiences in quality assessment or supply chain management to improve your current performance?
• What important information must you review before you begin, such as the company’s Standard Operating Procedures (SOPs) for distribution, relevant regulatory guidelines for recalls, and the specific requirements for the product in question?
• How will you prepare to evaluate the effectiveness of the recall process, and what resources (such as regulatory expectations or previous deviation reports) will you use to benchmark your findings?

In action

During the activity, is anything unexpected occurring?

• What is happening right now that feels surprising or different from what you anticipated while you are completing the distribution documentation or evaluating the recall procedures?
• Are you noticing any discrepancies in distribution records or missing information in the recall Standard Operating Procedures (SOPs) that you did not expect to find?
• Are you identifying a systemic weakness in the distribution chain that was not previously highlighted in quality reports?
• How is this current experience comparing to your previous experiences with similar quality assessment or distribution activities?
• Are you encountering unexpected technical challenges when verifying compliance with Good Distribution Practice (GDP) for specific medicinal products?

How are you reacting to the unexpected development?

• How are you adjusting or changing your approach to the distribution or evaluation task in response to the situation as it unfolds?
• Are you responding to the situation appropriately, for example, by pausing to consult GDP principles or seeking advice from the Releasing Officer?
• Is the unexpected development affecting your ability to undertake the activity independently, or are you currently seeking immediate support?
• How are you feeling in this moment? Are you finding it difficult to adapt, or do you feel positive and confident that you can reach a successful conclusion?
• Are you able to quickly re-prioritise your analysis of distribution logs or batch records when new information emerges?

What is the conclusion or outcome?

• How are you ensuring that you are working within your scope of practice as you address this unexpected event?
• Do you recognise when a distribution issue or a flaw in the recall process requires immediate escalation to a senior colleague to ensure patient safety and product availability?
• What are you learning as a result of the unexpected development while it is still unfolding?
• Are you gaining a deeper understanding of the importance of traceability or the complexities of applying Quality Risk Management (QRM) to effective recall planning through this real-time challenge?
• What is the immediate outcome of your reaction—have you successfully mitigated a risk or identified a necessary improvement for the department’s quality management system?

On action

What happened?

• Summarise the key points of your experience distributing the product and completing the required legal and quality documentation.
• Detail the key elements of the recall process you evaluated, including the triggers for initiation and the roles of various stakeholders.
• Consider specific events or interactions that felt important, such as discussing the implications for patient safety and product availability with the Releasing Officer.
• Include your feelings during the experience, particularly the weight of responsibility involved in ensuring product traceability.
• Highlight any ‘reflect-in-action’ moments where you adapted in real-time, such as how you responded to a surprising discrepancy in distribution records or an ambiguity in the recall Standard Operating Procedure (SOP).

How has this experience contributed to your developing practice?

• Identify the specific learning you gained regarding Good Distribution Practice (GDP) and how the distribution process directly impacts product quality and integrity.
• Assess the strengths you demonstrated in documentation accuracy and the knowledge gaps that became evident when suggesting improvements to the recall process.
• Compare this experience against previous engagements, such as attending quality meetings or observing the release of finished products. Has your practice improved in identifying potential risks within the supply chain?
• Identify the challenges you faced—for example, evaluating complex traceability chains—and how your reaction affected your ability to work independently.
• Acknowledge any instances where you needed to seek advice or escalate a concern to ensure you remained within your scope of practice, especially regarding potential product non-conformance.

What will you take from the experience moving forward?

• Identify the ‘next steps’ you will take to support the assimilation of your learning regarding the interdependence between distribution documentation and successful recall outcomes.
• Based on feedback, determine what you will do differently next time you are faced with a similar distribution scenario or an unexpected deviation in the recall plan.
• Reflect on whether your approach would change if a real-world recall were initiated; for instance, how would you more effectively apply Quality Risk Management (QRM) to investigate the problem?
• Identify if you need to practise specific aspects of the activity further, such as conducting rapid traceability audits, refining your understanding of regulatory requirements for recalls, or improving documentation efficiency.

Beyond action

Have you revisited the experiences?

• Have you reviewed your actions and identified points of improvement from your previous attempts at product distribution and recall evaluation? For example, have you successfully addressed previously identified gaps in your understanding of Good Distribution Practice (GDP) or documentation accuracy?
• Are you now ready to demonstrate new learning—such as refined techniques for ensuring batch traceability or more robust risk assessment during a recall simulation—into your current practice?
• Have you engaged in professional storytelling with peers, near-peers, or colleagues regarding the complexities of the supply chain? Consider if your view of a product recall (e.g., the speed of response or the impact on product availability) has transformed because of exchanging experiences with others.

How have these experiences impacted upon current practice?

• How has the learning gained from repeated distribution activities supported your preparation for ‘in-person’ assessments? For instance, how does this activity help you prepare for an Observed Communication Event (OCE) such as “Present audit finding and recommendations at a quality meeting” or a Case-Based Discussion (CBD) regarding problem investigation?
• How has your practice in managing Quality Risk Management (QRM) and Good Manufacturing Practice (GMP) developed over time? Do you find you are more intuitive when identifying potential weaknesses in the distribution chain that could necessitate a recall?
• Reflect on how your ability to recognise when a distribution issue or quality defect is beyond your scope of practice has evolved. Can you more confidently identify the exact moment you must escalate a concern to the Releasing Officer or a senior colleague to ensure patient safety?
• How have these experiences reinforced your understanding of the Clinical Scientist’s role in the wider area of pharmaceutical quality assurance and the integrity of the medicinal supply chain?

Relevant learning outcomes

#	Outcome
# 1	Outcome Describe the working practices of pharmaceutical production.
# 3	Outcome Perform a range of manufacturing activities, using specialist equipment, in accordance with requirements for GMP and pharmaceutical quality management systems.
# 5	Outcome Perform activities to support safe storage and distribution of medicinal products applying the principles of Good Distribution Practice (GDP).
# 6	Outcome Apply the principles of quality risk management to the manufacturing process.